Workflow
股份回购
icon
Search documents
贵州茅台:拟15亿-30亿元回购股份用于注销
Xin Lang Cai Jing· 2025-12-24 10:03
Group 1 - The company plans to repurchase shares through centralized bidding, with an amount not less than 1.5 billion and not exceeding 3 billion, at a price not exceeding 1863.67 yuan per share [1] - The expected number of shares to be repurchased is between 804,864 and 1,609,727, accounting for 0.0643% to 0.1285% of the total share capital [1] - The repurchase funds will come from the company's own funds and will be used for cancellation and reduction of registered capital [1] Group 2 - The implementation period for the repurchase is within six months from the date of approval by the shareholders' meeting [1] - Currently, the controlling shareholder, actual controller, and senior management have no plans to reduce their holdings in the next three to six months [1] - The controlling shareholder previously planned to increase holdings, having already acquired 797,125 shares by 2025, with a payment of 1.1611962 billion yuan [1]
新点软件:累计回购114万股
Mei Ri Jing Ji Xin Wen· 2025-12-24 08:44
Group 1 - The core point of the article is that New Point Software has announced a share buyback program, having repurchased 1.14 million shares, which represents 0.35% of its total share capital of approximately 322 million shares, with a total expenditure of about 29.98 million RMB [1] - The highest price for the repurchased shares was 27.18 RMB per share, while the lowest price was 24.21 RMB per share [1] - For the year 2024, the revenue composition of New Point Software is reported to be 99.55% from software-related activities and 0.45% from other businesses [1] Group 2 - As of the latest update, New Point Software has a market capitalization of 8.1 billion RMB [2]
东阿阿胶股份有限公司 关于以集中竞价交易方式首次回购公司股份的公告
Core Viewpoint - The company, Dong'e Ejiao Co., Ltd., has approved a share repurchase plan to buy back its shares through centralized bidding, with a maximum price of RMB 72.08 per share, aiming to enhance shareholder value and reduce registered capital [1]. Group 1: Share Repurchase Plan - The company will use its own or raised funds to repurchase shares, with a minimum of 138,730 shares and a maximum of 277,470 shares based on the upper price limit [1]. - The repurchase period will last no more than 12 months from the approval date by the shareholders' meeting [1]. - All repurchased shares will be canceled, leading to a reduction in the company's registered capital [1]. Group 2: First Share Repurchase Execution - On December 23, 2025, the company executed its first share repurchase, acquiring 406,800 shares, which is approximately 0.06% of the total share capital [2]. - The highest transaction price was RMB 49.22 per share, while the lowest was RMB 49.05 per share, with a total transaction amount of RMB 19,997,635 (excluding transaction fees) [2]. Group 3: Compliance and Regulations - The company adhered to the relevant regulations during the share repurchase, ensuring that the repurchase did not occur during periods that could significantly impact the stock price [3][4]. - The company will continue to implement the repurchase plan based on market conditions and will fulfill its information disclosure obligations as required by law [4].
福然德股份有限公司关于股份回购实施结果暨股份变动的公告
福然德股份有限公司 关于股份回购实施结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ■ 一、回购审批情况和回购方案内容 1、福然德股份有限公司(以下简称"公司")于2024年12月24日召开第三届董事会第十三次会议、第三 届监事会第十二次会议,分别审议通过《关于以集中竞价交易方式回购公司股份的议案》;公司于2024 年12月25日召开第三届董事会第十四次会议,审议通过《关于调整回购股份资金总额下限的议案》,综 上,同意公司使用4,000万元至8,000万元的自有资金及银行股票回购专项贷款以集中竞价交易方式回购 公司股份,并用于实施股权激励或员工持股计划。回购价格不超过人民币15.03元/股,该价格不高于董 事会通过回购股份决议前30个交易日公司股票交易均价的150%,回购期限为自董事会审议通过回购股 份方案之日起12个月内。 具体内容详见公司分别于2024年12月25日、2024年12月31日在上海证券交易所网站(www.sse.com.cn) 上披露的《福然德股份有限公司关于以集中竞价方 ...
中盐内蒙古化工股份有限公司关于股份回购实施结果暨股份变动的公告
Xin Lang Cai Jing· 2025-12-23 19:08
Core Viewpoint - The company, Zhongyan Inner Mongolia Chemical Co., Ltd., has successfully completed its share repurchase plan, acquiring a total of 9,036,570 shares, which represents 0.616% of its total share capital, with a total expenditure of approximately 67.04 million yuan [4]. Group 1: Share Repurchase Approval and Plan - The company approved a share repurchase plan on December 5 and December 23, 2024, allowing for a repurchase of shares using self-owned and raised funds, with a budget between 50 million yuan and 100 million yuan [2]. - The repurchase price is capped at 12.60 yuan per share, with at least 50% of the funds allocated for maintaining company value and shareholder rights [2]. Group 2: Implementation of Share Repurchase - The first repurchase was executed on January 3, 2025, and the plan was completed by December 22, 2025, with shares repurchased at a maximum price of 7.98 yuan and a minimum price of 6.71 yuan, averaging 7.42 yuan per share [4]. - The execution of the repurchase plan adhered strictly to legal regulations, and there were no discrepancies between the actual execution and the disclosed plan [4]. Group 3: Shareholder Transactions - The company's chairman, Zhou Jie, planned to increase his shareholding by investing between 150,000 yuan and 200,000 yuan starting from September 20, 2024, and successfully acquired 23,900 shares by January 7, 2025 [5][6]. - No other directors, senior management, or major shareholders engaged in buying or selling company shares during the repurchase announcement period [6]. Group 4: Share Changes - The company reported changes in shareholding, including the cancellation of 5,390,824 restricted shares and the listing of 4,612,662 restricted shares during 2025 [6]. Group 5: Handling of Repurchased Shares - All repurchased shares will be stored in a dedicated account, with a maximum of 50% allocated for employee stock ownership plans or equity incentives, and the remaining for maintaining company value [7]. - If the repurchased shares are not utilized within 36 months, they will be canceled according to relevant laws and regulations [7].
Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday - Ascentage Pharma Group (NASDAQ:AAPG), Century Aluminum (NASDAQ:CENX)
Benzinga· 2025-12-23 15:15
Group 1 - U.S. stocks experienced a decline, with the Dow Jones index falling approximately 0.1% on Tuesday [1] - Novo Nordisk A/S shares surged 8.6% to $52.26 following FDA approval of its Wegovy pill, marking the first approval of its kind globally [1] Group 2 - WW International Inc shares increased by 14.4% to $30.42 after launching an integrated GLP-1 program [2] - Lifezone Metals Ltd saw an 11.1% gain, reaching $4.43 [2] - Hycroft Mining Holding Corporation shares rose 9.1% to $26.75 [2] - Sable Offshore Corp gained 8.8% to $8.27 after receiving approval for the restart plans of the Las Flores Pipeline system [2] - Ascentage Pharma Group International shares increased by 8.4% to $28.17 [2] - Lionsgate Studios Corp shares surged 8.3% to $9.06 after expanding access to its ad-supported streaming inventory [2] - Critical Metals Corp gained 7.6% to $8.65 [2] - ZIM Integrated Shipping Services Ltd shares rose 7.4% to $21.35 after receiving acquisition proposals and evaluating offers [2] - mF International Limited shares increased by 7.1% to $21.38 [2] - Intrepid Potash Inc shares rose 7.1% to $29.06 [2] - Sellas Life Sciences Group Inc gained 6.8% to $2.82 [2] - StoneCo Ltd shares increased by 5.8% to $14.96 after the board authorized a new share repurchase program of up to R$2 billion [2] - Century Aluminum Co shares rose 5% to $39.02, with Wells Fargo analyst maintaining an Overweight rating and raising the price target from $37 to $46 [2]
12月23日增减持汇总:佰维存储等5股增持 紫光股份等6股减持(表)
Xin Lang Cai Jing· 2025-12-23 13:35
Summary of Key Points Core Viewpoint - On December 23, several A-share listed companies disclosed their share buyback and reduction plans, indicating varying levels of confidence in their respective companies' future performance [1]. Group 1: Share Buybacks - Bowe Storage has completed a share buyback of 140 million yuan and plans to cancel the repurchased shares [2][3]. - BioShares intends to increase its stake in the company by 50 million to 100 million yuan [2][3]. - Huaxin Cement plans to buy back shares worth no less than 200 million yuan and no more than 400 million yuan [2][3]. - Weimais plans to repurchase shares for an amount between 50 million and 100 million yuan [2][3]. - Nova Star Cloud has secured financing support for a share buyback of up to 135 million yuan [2][3]. Group 2: Share Reductions - Hangyu Micro's shareholders Yan Jun and Wu Yuqi plan to reduce their stakes by no more than 1.66% and 0.36%, respectively [4]. - Yiwang Yichuang's shareholder Zhang Fan intends to reduce his stake by no more than 2.50% [4]. - Quan Feng Technology's fourth-largest shareholder, Hesheng Health, reduced its holdings by 31.89 million shares from December 19 to December 22 [4]. - Unisplendour's shareholder Chang'an Trust plans to reduce its stake by no more than 1% [4]. - Happy Home's shareholder has preliminarily set the transfer price at 19.43 yuan per share [4]. - Okoyi's shareholder Yuan Meihe plans to reduce his stake by no more than 1.89% [4].
微芯生物:累计回购53.82万股公司股份
Ge Long Hui· 2025-12-23 12:25
格隆汇12月23日丨微芯生物(688321.SH)公布,2025年12月23日,公司已完成本次股份回购。公司通过 上海证券交易所交易系统以集中竞价交易方式累计回购公司股份53.82万股,占公司总股本的0.13%,回 购成交的最高价为29.05元/股、最低价为26.8元/股,支付的资金总额为人民币1499.67万元(不含印花 税、交易佣金等交易费用)。 ...
腾讯控股:12月23日回购105.1万股,回购总金额6.36亿港元
Xin Lang Cai Jing· 2025-12-23 12:08
Share Issuance - On December 23, 2025, 655 new shares were issued due to the exercise of stock options at a price of 276.81 HKD, based on the 2023 stock option plan [1][2] - The total number of issued shares increased to 9,130,646,362 [1][2] Share Buyback - From December 8 to 23, a total of 12,617,000 shares were repurchased for cancellation, with daily buyback volumes ranging from 1,035,000 to 1,067,000 shares [1][2] - The buyback price ranged from 595.75 to 614.08 HKD, with 1,051,000 shares repurchased on December 23 at transaction prices between 602.5 and 613.5 HKD, totaling 636 million HKD for that day [1][2] Buyback Authorization - The buyback authorization was approved by the shareholders' meeting on May 14, 2025, allowing a maximum repurchase of 918,901,866 shares [1][2] - As of now, 97,765,000 shares have been repurchased, representing 1.06% of the total shares issued at the time of authorization [1][2] - The 30-day suspension period following the buyback ends on January 22, 2026 [1][2] Impact on Share Structure - All repurchased shares will be canceled, with no stock held in reserve [1][2] - The ongoing buyback reflects the company's confidence in its stock price and long-term value [1][2]
东阿阿胶:首次以集中竞价交易方式回购股份近2000万元
Xin Lang Cai Jing· 2025-12-23 11:26
东阿阿胶公告称,公司于2025年12月23日首次以集中竞价交易方式回购股份,数量406,800股,约占总 股本的0.06%,最高成交价49.22元/股,最低成交价49.05元/股,成交总金额1999.76万元。此前,公司于 2025年12月22日股东会审议通过回购方案,回购价格不超72.08元/股,数量下限为138.73万股,上限为 277.47万股,实施期限不超12个月,回购股份将全部注销并减少注册资本。 ...